Richard J. Gregory

Richard J. Gregory is a declared insider at 2 companies; the most frequent names are ImmunoGen, Inc. and Q32 Bio Inc. Over a trading history stretching from 8 January 2016 to 18 November 2019, the count stands at 9 filings.

The open-market side counts 1 purchase for €27k alongside 6 sales for €544k. Sales outweigh purchases by €517k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 1 option exercise.

The newest entry dates from 29 January 2020: an option exercise of €293, in Q32 Bio Inc. The clock since the last published purchase (3 November 2016) now reads 3,658 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.